Premium
Five‐year outcomes of rapid‐deployment aortic valve replacement with the Edwards Intuity valve
Author(s) -
Pelce E.,
Porto A.,
Gariboldi V.,
Ben Lagha A.,
Amanatiou C.,
Collart F.,
Theron A.
Publication year - 2021
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/jocs.15665
Subject(s) - medicine , periprosthetic , valve replacement , prosthesis , regurgitation (circulation) , surgery , stroke (engine) , aortic valve replacement , retrospective cohort study , aortic valve , cardiology , stenosis , arthroplasty , mechanical engineering , engineering
Background This report presents 5‐year outcomes of the rapid‐deployment Edwards Intuity valve in a prospective, single‐center study. Methods All patients who underwent an aortic valve replacement (AVR) with an Edwards Intuity bioprosthesis at La Timone Hospital, Marseille, France, from July 2012 to June 2015 were assessed over a 5‐year follow‐up period. The primary outcome was overall mortality at 5 years. Secondary outcomes were reoperation, overall mortality and stroke, cardiovascular mortality, composite endpoints defined by the updated Valve Academic Research Consortium‐2 (VARC‐2), periprosthetic regurgitation, prosthesis‐patient mismatch, and the need for new pacemaker implantation. Results In total, 170 consecutive patients were assessed, of which 67.1% were males. The mean age was 76 years, mean EuroSCORE II was 3.5% and 5‐year overall mortality was 12.4%. At 5 years, reoperation was 2.9%, overall mortality and stroke was 4.1% per patient‐year, and cardiovascular mortality was 4.7%. VARC clinical efficacy and VARC time‐related valve safety were achieved in 46.0% and 59.9% of patients, respectively. At one month VARC device success was 71.2% and VARC early safety was 87.1%. At one year, mild and moderate periprosthetic regurgitation were 2.4% and 0.6%, respectively, and moderate and severe prosthesis‐patient mismatch were 18.8% and 4.8%, respectively. Conduction disturbances needing new PPI occurred in 3.5% patients. Conclusion The 5‐year outcomes of AVR with the Edwards Intuity valve system demonstrate satisfactory midterm safety and excellent haemodynamic performance.